ABSTRACT PDX1 is a homeodomain transcription factor essential for pancreatic development and mature beta cell function. Homeodomain proteins typically recognize short TAAT DNA motifs in vitro: this binding displays paradoxically low speci®city and af®nity, given the extremely high speci®city of action of these proteins in vivo. To better understand how PDX1 selects target genes in vivo, we have examined the interaction of PDX1 with natural and arti®-cial binding sites. Comparison of PDX1 binding sites in several target promoters revealed an evolutionarily conserved pattern of nucleotides¯anking the TAAT core. Using competitive in vitro DNA binding assays, we de®ned three groups of binding sites displaying high, intermediate and low af®nity. Transfection experiments revealed a striking correlation between the ability of each sequence to activate transcription in cultured beta cells, and its ability to bind PDX1 in vitro. Site selection from a pool of oligonucleotides (sequence NNNTAATNNN) revealed a non-random preference for particular nucleotides at the¯anking locations, resembling natural PDX1 binding sites. Taken together, the data indicate that the intrinsic DNA binding speci®city of PDX1, in particular the bases adjacent to TAAT, plays an important role in determining the spectrum of target genes.
INTRODUCTION
Homeodomain proteins are a large family of transcription factors possessing the hallmark 60 amino acid homeodomain that is highly conserved from yeast to human. Since their initial characterization in 1984 (1,2), homeodomain proteins have been studied extensively, because of the crucial role they play in a broad range of developmental processes in virtually all metazoan organisms (3) . Through their ability to regulate gene expression, these proteins apparently act as switches that control the activities of batteries of genes during development (4) .
Structural studies have revealed that the homeodomain consists of an N-terminal arm and three a helices (5), a structure that confers on the proteins the key property of sequence-speci®c binding to DNA. Since the repertoire of target genes for most homeodomain proteins is poorly de®ned, studies of DNA binding speci®city have generally focused on in vitro analysis of their interactions with arti®cial DNA sequences. This approach has generated a detailed picture of DNA contacts made by a variety of homeodomains [reviewed in (6±8)]. Homeodomains typically bind a core TAAT sequence, with additional binding speci®city contributed by base-speci®c interactions with the 2 nucleotides 3¢ of the TAAT motif (6) . However, numerous studies have indicated that the speci®city and af®nity of in vitro DNA binding is relatively low, despite the fact that these proteins function in a very precise and speci®c manner during development and cell differentiation (9) .
Several explanations for this`homeodomain paradox' have been proposed. For instance, additional DNA binding regions present on a subset of homeodomain proteins (e.g. the POU domain family) have been shown to substantially increase DNA binding af®nity and speci®city (10) . Alternatively, it has been proposed that cofactors may facilitate the high speci®city of action observed in vivo (11) . Indeed in recent years, members of the PBC family of homeodomain proteins have been shown to serve as cofactors of homeodomain proteins (12) . PBC proteins are capable of interacting with a subclass of homeodomain proteins via a conserved hexapeptide motif located N-terminal of the homeodomain, thereby expanding the DNA recognition sequence (13, 14) . A third explanation, the`widespread binding' model, proposes that multiple monomer binding sites exist in target gene promoters, thereby increasing promoter occupancy, perhaps aided by cooperative binding mechanisms (15) .
PDX1 (also known as IPF1, IDX-1 and STF-1) is a highly conserved 284 amino acid homeodomain protein expressed selectively in pancreatic precursor cells and in mature pancreatic beta cells (16) . It is essential for pancreas development, since loss of PDX1 function results in agenesis of the organ both in mice (17) and in humans (18) . PDX1 is also needed for normal function of mature pancreatic beta cells (19) . Indeed under some circumstances, PDX1 may be suf®cient to activate a pancreatic developmental program in non-pancreatic lineages, since ectopic expression of PDX1 in *To whom correspondence should be addressed. PDX1 represents one of the few homeodomain proteins for which several potential target genes with well-characterized promoters [e.g. the insulin, islet amyloid polypeptide (IAPP) and pancreatic glucokinase genes] have been identi®ed (23±25). Yet the mechanism whereby these genes are selectively activated remains unclear. PDX1 contains a hexapeptide motif N-terminal to the homeodomain, and it has been shown that heteromeric complexes of PDX1 with PBC family members, e.g. PBX and Meis proteins, are able to bind with high af®nity to the TAGTTAAT elements on the somatostatin (26) and elastase I (27) gene promoters. However, this high-af®nity site is not found on the majority of potential beta cell target promoters (26) . Thus, interaction with PBC proteins may not be essential for PDX1 function in mature pancreatic beta cells. This is consistent with the observation that the hexapeptide appears to be dispensable for activation of the insulin gene promoter in transgenic mice (28) , and raises the possibility that selection of target genes is accomplished by PDX1 alone, perhaps as a monomer.
The aim of this study was to analyze the binding site preference of PDX1 with a view to better understanding the mode of action of the protein, and to help de®ne the repertoire of target genes. Upon comparison of PDX1 binding sites on the insulin gene and other putative PDX1 target genes, we observed a strong conservation of nucleotides on either side of the TAAT core. This prompted us to test the functional signi®cance of these¯anking nucleotides. Our results indicate that PDX1 is able to discriminate in vitro among potential binding sites on natural promoters and on arti®cial binding sites, by virtue of 3 bp¯anking the TAAT motif. By transfecting cultured beta cells with reporter genes bearing wild-type and mutated promoters, we showed that thesē anking sites are also important for PDX1 action in vivo. The unanticipated ability of PDX1 to recognize an extended DNA sequence may help to explain how target gene preference of this crucial gene is determined in vivo.
MATERIALS AND METHODS

Plasmids
The plasmids pGL3.Synt.LUC and pRL.RSV have been described previously (29) . The unique BamHI site in pGL3.Synt.LUC was destroyed by ®ll-in and religation, to produce pGL3.Synt-DB. For mutations in the A1 region (±83 to ±74), the backbone reporter plasmid pGL3.S8a-DB was made by substituting the rat insulin I gene promoter region between PstI (±160) and HindIII (+1) in pGL3.Synt-DB with that from pS8a-CAT, a derivative of the plasmid pOK1 that contains a unique, transcriptionally silent BamHI site (±85) just upstream of the A1 element in the rat insulin I gene promoter (30) . This construct was ®rst digested at the unique HindIII site (+1), dephosphorylated, and then digested at the unique BamHI site (±85). Synthetic oligonucleotides with the desired mutations in the A1 TAAT¯anking bases were annealed and ligated, together with a 64-bp linker, between the BamHI (±85) and HindIII (+1) sites of pGL3.S8a-DB. The 64-bp linker spanning the positions from ±63 to +1 was produced by annealing the following oligonucleotides: 64-top d(AAGTCCAGGGGGCAGAGAGGAGGTGCTTT-GGACTATAAAGCTAGTGGAGACCCAGTAACTCCCA) and 64-bot d(AGCTTGGGAGTTACTGGGTCTCCACTAG-CTTTATAGTCCAAAGCACCTCCTCTCTGCCCCC). For mutations in the A3 region (±216 to ±207), a unique EcoRI site (±250) was introduced in pGL3.Synt.LUC using the Quick ChangeÔ site-directed mutagenesis kit (Stratagene). This construct was then digested at the EcoRI site, dephosphorylated and subsequently digested at the unique AvrII site (±205). Synthetic oligonucleotides with the desired mutations in the A3 TAAT¯anking bases were then annealed and ligated, together with an 18-bp linker, between the EcoRI and AvrII sites. The 18-bp linker spanning the positions from ±252 to ±235 was produced by annealing the following oligonucleotides: 18-top d(AATTCCTTCATCAGGCCA) and 18-bot d(GCCAGATGGCCTGATGAAGG). Double mutations were then made by substituting the wild-type rat insulin I gene promoter region between the PstI (±160) and HindIII (+1) sites of the A3 type mutations with those from the A1 mutations. The constant 64-and 18-bp linkers were phosphorylated using polynucleotide kinase prior to ligation. The relevant regions of recombinant plasmids were veri®ed by DNA sequencing.
Cell culture and transfections
Hamster insulinoma cells HIT (subclone M2.2.2) (31,32) were cultured in Dulbecco's modi®ed Eagles medium in the presence of 10% fetal calf serum, penicillin (200 IU/ml) and streptomycin (100 mg/ml). Cells were transfected using the calcium-phosphate co-precipitation procedure (33) . HIT cells were plated 12 h before transfection on six-well plates at 2.5 Q 10 5 cells/well. Cells were cotransfected with 400 ng of the ®re¯y luciferase reporter plasmid containing the rat insulin I gene promoter (wild type or mutated) and 100 ng of the Renilla luciferase (pRL.RSV) internal control plasmid. Fire¯y luciferase activity was measured and normalized according to the Renilla luciferase activity (29) . Each experiment was performed in duplicate at least three times. Results shown are mean T SE.
Electrophoretic mobility shift assay (EMSA)
Nuclear protein extracts for EMSA were prepared from HIT cells as described previously (34) . Complementary synthetic oligonucleotides, diluted to a ®nal concentration of 5 mM in 2.5 mM HEPES pH 7.9, 15 mM KCl, 1% glycerol and 0.5 mM dithiothreitol (DTT) were heated at 85°C for 3 min, and allowed to anneal by slow cooling (2±3 h) to room temperature. Double-stranded oligonucleotides (5 pmol) were endlabeled using DNA polymerase I (Klenow fragment) in the presence of 50 mCi [a-32 P]dATP as described (34) . The speci®c activity obtained was typically 1±2 Q 10 3 c.p.m./fmol. EMSA experiments were carried out as described previously (34) , with the following modi®cations. For competition experiments, nuclear extract (2±3 mg protein) was incubated for 10 min on ice in 10 ml of EMSA binding buffer (25 mM HEPES pH 7.9, 150 mM KCl, 10% glycerol, 5 mM DTT) containing 600 ng of poly dI±dC (Sigma) and 600 ng of poly dA±dT (Sigma). Radioactive probe (~20 000 c.p.m.) containing the desired molar excess of unlabeled DNA competitor in EMSA binding buffer was then added, and incubation was allowed to continue for an additional 20 min on ice. Following electrophoresis on non-denaturing polyacrylamide gel, the dried gels were analyzed by phosphorimager (Bio-Imaging Analyzer, BAS-2500; Fuji). The extent of DNA binding was calculated using Image Gauge 3.41 software (Fuji) and compared with that observed in the absence of competitor DNA. Data presented are mean T SE from at least three independent experiments. Apparent equilibrium dissociation constants (K d ) were calculated by analysis of competition binding data using the equation of Cheng and Prusoff (35) , under conditions where a low percentage (<25%) of radioactive DNA is bound by PDX1. For this purpose, IC 50 
Selection and ampli®cation of binding sites (SAAB)
Mouse PDX1 was expressed as a glutathione S-transferase (GST) fusion protein in Escherichia coli strain BL-21. The recombinant protein was puri®ed by batch puri®cation using glutathione±Sepharose 4B beads (Pharmacia Biotech). Oligonucleotide selection was performed with a DNA fragment containing degenerate bases at three positions on both sides of the ATTA core¯anked by non-random sequences: d(GATCGACGTCCAGTGGATCCTTGANNNATTANNN-GATGCCGGCAAGACTGGGAACAGTAG). The singlestranded oligonucleotide containing the random sequence was made double stranded by annealing with an oligonucleotide complementary to the 3¢ non-random sequence: d(CTACTGTTCCCAGTCTTG) (SAAB bot), and ®ll-in reaction using PCR in the presence of 50 mCi [a- 32 PCRs were carried out in separate tubes for 10, 15 and 20 cycles. Aliquots (5 ml) were then resolved by agarose gel electrophoresis. DNA derived from PCRs showing ef®cient incorporation of radioactivity yet remaining within the exponential PCR range, were incubated with GST±PDX1 protein (270 ng) and processed as for EMSA. DNA from the resulting DNA±protein complexes was subjected to three additional cycles of binding, EMSA and puri®cation essentially as described (36) . After the fourth round of selection, the eluted DNA was ampli®ed by 25 cycles of PCR and cloned into the vector pGEM-T Easy (Promega). The recombinant clones were then sequenced.
RESULTS
Analysis of PDX1 in vitro binding sites within the insulin gene promoter
PDX1 has been shown to bind two different elements within the rat insulin I gene promoter: A1 and A3/4 ( Fig. 1A) (26,37± 39) . The A1 element contains a single TAAT motif (Fig. 1B) anked on both sides by a number of evolutionary conserved bases (Fig. 2) . A3/4 is a more complex element, containing from one to four TAAT sites that differ from each other both in their¯anking bases and in the degree of evolutionary conservation among the rat, mouse and human insulin gene promoters (Fig. 2) . The A3 region is highly conserved, whereas the A4 region is much more variable: only in the rat insulin I gene does it possess a core TAAT sequence. These differences suggest that PDX1 may act differently on these elements. Furthermore, the strong evolutionary conservation of PDX1 function implies that within the A3/4 element the protein will primarily act at the most conserved site, i.e. the A3 element. Thus, PDX1 may be able to distinguish TAAT of the A3 site from irrelevant TAATs nearby, by recognizing bases anking these TAATs. To test these ideas, we compared PDX1 binding to these naturally occurring sequences by competitive EMSA. Nuclear extracts from HIT cells were incubated with the rat insulin I A3/4 probe in the presence of increasing concentrations of competitor sequences containing the A1 and A3/4 elements from the rat insulin I and II gene promoters, or rat insulin I A3/4 element with a mutated A4 TAAT site (m1 A3/4) (Fig. 1B) . The E1 sequence, derived from the rat insulin 1 gene lacks a TAAT sequence and was used as a control for non-speci®c binding. We observed that all the A1 and A3/4 sequences tested displayed similar ability to compete for DNA binding (Fig. 1C) , indicating similar binding af®nities. Since the A3/4 element displays binding indistinguishable from that of m1 A3/4 that lacks A4, it seems likely that A3 is the primary binding site for PDX1 in this region, as expected from its evolutionary conservation.
Comparison of PDX1 binding properties among its potential target promoters in vitro
We analyzed the distribution of bases¯anking the TAAT core in a number of potential PDX1 target genes of rat, mouse and human. Alignments were compiled using the programs ClustalW (40), PileUp (GCG) and FindPatterns (GCG). We restricted the analysis to conserved sites that have been experimentally shown to be PDX1 responsive (39,41±46). The alignment reveals a clear, non-random distribution of nucleotides at three positions adjacent to the TAAT core sequences, and yields the consensus sequence CTCTAATGA/GC/G (Fig. 2) .
To compare the relative binding af®nities of these elements, we used competition EMSA with TAAT sites derived from several PDX1 target promoters. The rat insulin I gene A1 sequence (containing a single TAAT site) was used as a probe, and incubated with nuclear extract from HIT cells in the presence of increasing concentrations of competitor sequences containing TAAT elements from promoters of the following genes: rat insulin I (A1 element), rat pancreatic glucokinase [UPE-3 site (41)], rat IAPP [A2 site (42) ], mouse glucose transporter type 2 [GLUT2 TAAT site (45) ] and mouse albumin (24) (a gene expressed in liver but not in pancreas, and therefore not a PDX1 target) (Fig. 3A) . The sequences fell into three groups in terms of their ability to compete for binding (Fig. 3B) . The most effective competitor was A1 itself, while TAAT sequences from GLUT2 and albumin gene promoters showed low ef®ciency of competition; the sites from IAPP and pancreatic glucokinase gene promoters both displayed intermediate competition ef®ciency (Fig. 3B) .
The competition analysis allowed us to measure the af®nity of PDX1 binding to DNA, by calculating apparent K d values. The K d values obtained for PDX1 were in the nanomolar range, typical for homeodomain proteins (47±50). The apparent K d for the A1 binding site was 5.9 T 0.9 nM, signi®cantly lower (P < 0.005) than that for albumin and GLUT2 TAAT sites (24.6 T 1.8 and 24.7 T 4.2 nM, respectively).
In order to clarify the nucleotide requirements for DNA recognition by PDX1, we made a series of DNA competitors with nucleotide substitutions within the A1 probe that resemble the`unfavorable' bases from GLUT2 and albumin promoter TAAT elements (Fig. 3A) . The effects of these substitutions were tested by competition EMSA using HIT cell nuclear protein extracts. Simultaneous substitutions both upstream and downstream of TAAT (G5C + C2TÐas in albumin, and G4A + C1AÐas in GLUT2) led to a substantial decrease in PDX1 binding, although the extent of the effect was less than that observed for the corresponding TAAT elements from the albumin and GLUT2 promoters (Fig. 3C) . Therefore, the 2 nt mutated in each case are important in determining binding af®nity, but are insuf®cient to explain completely the differences between high and low af®nity TAAT core sequences.
Effect of TAAT¯anking bases in vivo
To assess the physiological role of TAAT¯anking nucleotides within PDX1 binding sites, we made a series of reporter plasmids based on the ®re¯y luciferase reporter gene under control of the rat insulin I gene promoter. For this purpose, the A1 site (TAAT and three bases¯anking it on both sides) was substituted with the corresponding sequences from the previously examined PDX1 binding sites from the promoters of the following genes: rat insulin I (A3 site), IAPP, pancreatic glucokinase, GLUT2 and albumin (see Fig. 2 for sequence details). The activities of these reporter plasmids were then compared with that of the wild-type rat insulin I gene promoter following transient transfection of HIT cells (Fig. 4) . As expected, the A3 sequence, which has PDX1 binding af®nity similar to A1, showed activity essentially identical to the wildtype promoter (104%). On the other hand, the TAAT sequences from the GLUT2 and albumin promoters, that display weak PDX1 binding in vitro, showed signi®cantly weaker promoter activity (23 and 49%, respectively). The UPE-3 site from the pancreatic promoter of the glucokinase gene (moderate PDX1 binding in vitro) showed intermediate activity (74%). The IAPP site (PDX1 binding similar to that of glucokinase) produced unexpectedly high (106%) promoter activity, probably indicating involvement of additional parameters in vivo not detected in vitro by EMSA, that are beyond simple PDX1±DNA interactions. Conceivably, the presence of an intact A3 site may partially compensate for a suboptimal binding site in the A1 location.
To con®rm these results, we made a series of double mutations in the rat insulin I gene promoter with substitutions of both A1 and A3 sites by the TAAT elements from albumin and GLUT2 genes (Fig. 4) . Since the A3 and A4 sites are located very close to each other, we designed substitutions within A3 that involved only the 3 nt downstream of the TAAT site on the sense strand, thereby maintaining the wildtype A4 sequence. Simultaneous replacement of both A1 and A3 regions with the corresponding sequences from albumin and GLUT2 genes led to a further substantial reduction in promoter activity, as compared with single mutations, to 7 and 9%, respectively (Fig. 4) . Taken together, our results indicate that the TAAT core is not suf®cient to bring about activation of the promoter, and that 3 bp adjacent to the core play an important role in determining target gene selection both in vitro and in vivo. Further, since the TAAT motif from the GLUT2 promoter shows inef®cient binding in vitro and functions relatively inef®ciently in vivo, this promoter seems unlikely to serve as a direct target of PDX1 action.
SAAB analysis of PDX1 binding
In order to determine systematically the in vitro DNA binding speci®city of PDX1, we used the SAAB procedure (51). GST±PDX1 fusion protein was expressed in bacteria and puri®ed using glutathione±Sepharose beads. The DNA binding properties of this puri®ed GST±PDX1 were assessed by EMSA analysis. This recombinant protein speci®cally binds the A1 DNA, and is ef®ciently competed with unlabeled A1, but not E1 (Fig. 5) , indicating DNA binding properties similar to that of native PDX1. We used this puri®ed GST±PDX1 protein to select sequences possessing optimal TAAT¯anking bases. Figure 4 . Effect of TAAT¯anks on rat insulin I gene promoter activity. A series of ®re¯y luciferase reporter plasmids containing wild-type or mutated rat insulin I gene promoter were constructed using the plasmid pGL3.Synt.LUC as described in Materials and Methods. TAAT elements from rat insulin I A3 (A3), pancreatic glucokinase (bGK), IAPP, mouse GLUT2 and rat albumin (Alb) promoters replacing the A1 region of the rat insulin I gene promoter are indicated under the heading`A1'; those replacing the A3 region are shown under the heading`A3', respectively. HIT cells were transfected with the indicated reporter plasmids. The ®re¯y luciferase activity was normalized to the activity of the internal control Renilla luciferase gene driven by RSV promoter. The normalized activities of the modi®ed promoters are expressed (mean T SE, n b 3) relative to that of the wild-type rat insulin I gene promoter. Comparison of the 30 sequences obtained after four rounds of site selection shows a strikingly non-random distribution of TAAT¯anking bases (Fig. 6A ) resembling natural PDX1 binding sites. The sequences fall into three different groups according to the number and relative position of the TAAT core (Fig. 6A) . The ®rst group (seven clones, designated SAAB1) has consensus sequence (based on most frequently occurring nucleotides) ACCTAATGAG, resembling (three out of six bases identical) the A1 site of insulin gene promoters (CCTTAATGGG) (Fig. 6B) . The largest group (17 clones, SAAB2) contains a palindromic double TAAT sequence (TAATTA) with consensus sequence A/CGCTAATTAC. This sequence is closely similar (®ve out of six bases identical) to the insulin gene A3 consensus site (CTCTAATTAC) (Fig. 6B) . The third group (six clones) also contains a palindromic double TAAT site, but of opposite orientation, generating a CATTAATAGG consensus sequence that we did not observe in putative PDX1 target promoters analyzed (Fig. 6A) . Thus, the majority of sequences selected by SAAB are related to natural PDX1 binding sites in the insulin gene promoters.
The SAAB approach is expected to select sequences of relatively high binding af®nity. To validate the effectiveness of the SAAB procedure, we examined the properties of the SAAB1 consensus sequence. Natural TAAT¯anks of the A1 probe were substituted with the corresponding bases from the single TAAT consensus sequence (Fig. 7A ) and analyzed by competition EMSA. The relative PDX1 binding af®nity of this construct (designated SAAB1) was indistinguishable from that of the wild-type A1 sequence (Fig. 7B) , con®rming that the SAAB procedure indeed selected high af®nity binding sites.
DISCUSSION
In this study, we have examined the DNA binding speci®city of the key pancreatic transcription factor PDX1. Although the crucial role of PDX1 in pancreas development and beta cell gene expression is well established, the mechanism whereby it selectively activates genes and the identity of its target genes, particularly those activated during development, remain poorly understood. This is a re¯ection of our incomplete understanding of the actions of homeodomain proteins.
PDX1 contains a hexapeptide domain that permits dimerization with PBC proteins and binding to compound cis elements on the somatostatin and amylase promoters. However, since most pancreatic somatostatin-or amylaseproducing cells do not express PDX1 (52) , the signi®cance of the dimerization is not clear. Indeed it appears that binding sites for PDX1/PBC heterodimeric complexes are absent in several PDX1 target genes, e.g. the insulin gene (26) . Furthermore, PDX1 protein bearing a mutation in the hexapeptide motif was able to partly rescue the phenotype of PDX1 knockout mice (28) . Thus, for at least some of the in vivo actions of PDX1, it appears that promoter recognition is mediated without involvement of PBC co-factors, perhaps through DNA binding by a monomer of PDX1. A key question therefore surrounds the mechanisms whereby PDX1 is able to select target genes as monomers.
A considerable amount of evidence suggests that the insulin gene represents a direct target of PDX1, including recent chromatin immunoprecipitation experiments showing that PDX1 is bound to the insulin gene promoter in vivo (24, 25) . We therefore initially examined the ability of PDX1 to discriminate among cis elements located in the insulin gene promoter, a well-characterized promoter which has been shown previously to contain two cis elements (A1 and A3/4) that are ef®ciently recognized in vitro by PDX1 (26) . Using a competition EMSA procedure, we showed that the A1 and A3 sequences were recognized with similar ef®ciency by PDX1. On the other hand, the A4 region was apparently not required for ef®cient binding. The A4 region has been shown previously to represent a binding site for the transcription factor HNF1a (53) . Interestingly, only in the rat insulin I gene does the A4 region contain a TAAT core: this region is not conserved in other characterized insulin gene promoters ( Figs  1B and 2) . Thus, A4 is unlikely to represent a physiologically relevant PDX1 target site. The data do indicate however, that the evolutionarily conserved A3 and A1 regions are the key determinants of PDX1 binding within the promoter. Furthermore, the differences between A1 and A3 on the one hand, and A4 on the other, indicate the likely contribution of additional nucleotides¯anking the TAAT core in determining the ef®ciency of PDX1 binding. In the case of A1 and A3, there is signi®cant conservation of at least 3 nt on either side of the TAAT motif.
PDX1 represents one of the few homeodomain proteins, for which several multiple well-characterized promoters have been identi®ed as potential direct targets. This enabled us to correlate DNA binding preferences of PDX1 to the occurrence of particular bases¯anking the TAAT core site in the native target sequences. To our knowledge, this represents the ®rst time such an analysis has been performed for a homeodomain protein. We observed a strikingly non-random organization of bases¯anking the TAAT core. Utilizing the quantitative EMSA assay, we were able to show that these binding sites could be classi®ed into several groups based on their relative binding af®nities. Thus, the IAPP and pancreatic glucokinase sites bind relatively ef®ciently, though at signi®cantly lower af®nity than the insulin A1 and A3/4 sites. In contrast, the GLUT2 site exhibits lower binding af®nity, similar to that shown by a site contained within the albumin promoter, a gene expressed selectively in liver cells, and therefore not a PDX1 target gene. These analyses clearly indicate that the PDX1 protein possesses the ability to discriminate in vitro between potential binding sites based on the nucleotides¯anking the TAAT core.
To examine systematically the in vitro binding preference of PDX1, we utilized the SAAB procedure (51) with oligonucleotides degenerate at the 3 nt upstream and downstream of the TAAT core. The selected sequences fell into three groups showing a non-random distribution of nucleotides¯anking the TAAT core. Two of the groups bear a similarity to natural TAAT binding sites, particularly the A1 and A3 regions of the insulin gene promoter. To verify the ability of the SAAB-selected sequences to ef®ciently bind DNA, we used EMSA analysis. Indeed the SAAB1 sequence showed DNA binding af®nity indistinguishable from A1. These results con®rm that ef®cient PDX1 binding to DNA involves sequences¯anking the TAAT core, and that the A1 and A3 sites of the insulin gene promoter correspond to preferred binding sites. Thus, DNA recognition by PDX1 seems to involve at least two different mechanisms. When the TGATTAAT sequence is available, e.g. in the somatostatin promoter, PDX1 can bind as a heterodimer with a PBC family co-factor. Alternatively, PDX1 binds as a monomer to TAAT sequences different from TGATTAAT, with af®nities according to the¯anking bases as described in this study.
Previous studies have examined systematically the DNA binding preference of homeodomain proteins, and have observed a variable degree of sequence speci®city in bases anking the TAAT core (49, 54, 55) . Homeodomain proteins possessing a glutamine at residue 50 of the homeodomain, preferentially recognize the sequence TAAT G/T G/T (47). The signi®cance of¯anking bases in vivo has not been examined in detail previously. Utilizing the well de®ned beta cell transcriptional activity of the insulin gene promoter (56), we examined the in vivo signi®cance of the sequence variability surrounding the TAAT core. Indeed the observed in vivo activity showed a strong correlation with the ability of PDX1 to bind these TAAT elements in vitro. These data indicate that PDX1 is able to discriminate among TAAT elements both in vitro and in vivo by virtue of the¯anking nucleotides. Thus, the intrinsic DNA binding ability of monomer homeodomain proteins may play a more important role than suspected previously in determining the spectrum of target genes.
GLUT2 is an isoform of a membrane glucose transporter that is predominantly expressed in liver and pancreatic beta cells, and has been proposed to comprise part of the glucosesensing mechanism of the beta cell (57) . Yet the role of PDX1 in regulating GLUT2 gene expression is not clear. On the one hand, it has been shown that PDX1 expression activates the GLUT2 promoter (19, 45, 58) . On the other hand, transgenic mice expressing dominant negative FGFR1 show strongly reduced GLUT2, but essentially no effect on PDX1 expression, consistent with a model whereby PDX1 activates GLUT2 indirectly, through FGF signaling (59) . Chromatin immunoprecipitation studies support this idea, since PDX1 apparently does not bind to the GLUT2 promoter in vivo (24) . Our data indicate that this may be the result of an intrinsically low ef®ciency of binding to the TAAT element of the GLUT2 gene, rather than chromatin accessibility effects.
The molecular basis for the extended sequence recognition by PDX1 is not clear. A substantial number of three-dimensional structures of homeodomain±DNA complexes have been elucidated by X-ray crystallography and NMR (4). These reveal a conserved protein±DNA interface, in which sequence-speci®c DNA protein interactions are mediated principally by residues located in the so-called`recognition helix', the highly conserved third alpha helix of the homeodomain. These contacts involve primarily the TAAT core and 2±3 nt 3¢ terminal to the core. The structures reveal little or no sequence-speci®c interaction with nucleotides 5¢ from the core. Since evolutionary comparisons and the SAAB analysis clearly indicate a signi®cant role for at least 3 nt at the 5¢ side, previously unrecognized mechanisms must be involved. These may include additional protein±DNA interactions, perhaps mediated by amino acids outside the homeodomain, or through interactions involving indirect readout of the DNA sequence, or a possible involvement of heterodimeric DNA binding complexes with an as yet unidenti®ed partner protein. Detailed structure±function analysis of the binding sites will be required to better de®ne these issues.
Previous studies of homeodomain±DNA interaction have tended to focus on in vitro binding properties of homeodomain proteins, or the homeodomain itself (6) . The approach we have used differs from these in that we have also examined the functional signi®cance of homeodomain binding sequences in the context of a native full-length promoter of a bona ®de PDX1 target gene. Thus, we have been able to demonstrate that reduced in vitro binding to particular TAAT elements correlates with substantially reduced biological activity, and thereby pinpoints DNA binding speci®city of PDX1 as an important factor in determining the spectrum of target genes. As additional target genes of other homeodomain proteins are identi®ed, it will be possible to apply this type of analysis to better understand the process of selective gene regulation by these homeodomain proteins also.
